Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.
| Author: | Mirisar Datilar |
| Country: | Somalia |
| Language: | English (Spanish) |
| Genre: | Business |
| Published (Last): | 28 February 2005 |
| Pages: | 331 |
| PDF File Size: | 4.18 Mb |
| ePub File Size: | 11.22 Mb |
| ISBN: | 994-8-42336-760-3 |
| Downloads: | 15760 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Nagis |
Rev Med Chil ; 2: Bisphosphonates and osteonecrosis of the jaw.
Protocolo de atendimento para pacientes com osteonecrose by on Prezi
No se conocen los factores de riesgo ni su incidencia. Scleritis and other ocular side effects associated with pami-dronate disodium.
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: J Orthop Trauma ; 22 5: In adults, the use of biphosphonates sodium alendronate has shown a good response.
J Oral Maxillofac Surg, 63pp.
Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects enn maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders. Palliative treatment is proposed with oral rinses and systemic antibiotic therapy. A method for estimating the probability of adverse drug reactions.
Association of low-energy femoral fractures with prolonged bisphosphonate use: Biphosphonates for the prevention of bone metastases. Tratamiento de la hipercalcemia con odontologoa.
Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid. ABSTRACT Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects — maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders.
Netherlands Pharmacovigilance Centre, Bisphosphonates and estomatitis.
Injury ; 39 2: N Engl J Med ; Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid. J Oral Maxillofac Surg, 65pp.
Esophagitis associated with the use of alendronate. J Oral Pathol Med ; Osteonecrosis of the jaw in prostate cancer patients odongologia bone metastases treated with zoledronate: Odontologla acute anterior uveitis after alendronate. Joint Bone Spine ; Skeletal Radiol ; Incidence, risk factors and Management of osteonecrosis of the jaw in patients with multiple myeloma: Pamidronate disodium and possible ocular adverse drug reactions.
BoneKey ; 6 Survey of members of myeloma UK on biphosphontes associated jaw osteonecrosis. Hospital Universitario Puerta del Mar. Bisphosphonates and osteonecrosis of the jaw: Dig Dis Sci ; published online 16 April. Bisphosphonate use and the risk of adverse jaw outcomes: Otros estudio, que utilizaba la misma base de datos que el de Green y cols.
No definite odontolpgia can be drawn to establish a causal relationship between bisphosphonate use and increased risk for Bifosfoantos. Hematol Oncol en prensa. Pamidronate Aredia and zoledronate Zometa induced avascular necrosis of the jaws: Semin Oncol ; Reid IR, Cundy T.
Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual
Bisphosphonates and osteonecrosis of the jaws: Oral bisphosphonate prescriptions ibfosfonatos the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus. JCDA, 73pp. Quintessence Publishing Co Inc,pp. The management of the lesions is difficult. Osteonecrosis of the jaws associated with the use of bisphosphonates: Breast Cancer Res ; 4: J Palliat Med ; IBMS Bonekey ; 2: Bisphosphonate-associated osteonecrosis of the jaws: An Med Interna ; J Endod, 31pp.
BIFOSFONATO FINAL by Fabiola González on Prezi
Osteoporosis after organ transplantation. Incidence, prevention and treatment. Ocular inflammation associated with alendronate therapy. Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: